Deep Learning with Uncertainty Quantification for Predicting the Segmentation Dice Coefficient of Prostate Cancer Biopsy Images

arXiv:2109.00115 · eess.IV, cs.CV, cs.LG · Submitted 2021-08-31 · Read on arXiv

Listen

Radio episode about this paper

Transcript

Introduction to the show: ident: Electrical Engineering. The day in electrical engineering: signals, systems and the hardware that carries them.

Rosa: We're looking at the paper: "Deep Learning with Uncertainty Quantification for Predicting the Segmentation Dice Coefficient of Prostate Cancer Biopsy Images".

Dev: Here's the gist of the paper. Deep learning models trained with uncertainty estimations can provide more reliable predictions by correlating image-level uncertainties with segmentation performance metrics like Dice scores This study reports DLM’s trained with uncertainty estimations, using randomly initialized weights and Monte Carlo dropout, to segment tumors from microscopic Hematoxylin and Eosin dye stained prostate core biopsy histology RGB images Model Training Methodology The research utilized a Bayesian VGG-UNet CNN augmented with Monte Carlo dropout (MCD) for uncertainty quantification A Bayesian VGG-UNet CNN augmented with MCD was trained on prostate core biopsy images from the Grand Challenge for Pathology at MICCAI Gleason 2019 dataset Uncertainty quantification was applied in the decoder to mitigate noise during the encoding process, using MCD to approximate Bayesian inference by minimizing the posterior in a deep Gaussian Process Uncertainty quantification was applied in the decoder to mitigate noise during the encoding process, with MCD used to approximate Bayesian inference by minimizing the posterior in a deep Gaussian Process Model training involved hyperparameter optimization, five-fold cross-validation, and advanced performance metrics to ensure a comprehensive evaluation of the segmentation results Model training involved hyperparameter optimization, five-fold crossvalidation, and advanced performance metrics to ensure a comprehensive evaluation of the segmentation results The model was trained for 50 epochs with a batch size of two, using the Adam optimizer with a learning rate set at αlr = 0.001 The model was trained for 50 epochs with a batch size of two, using the Adam optimizer with a learning rate set at αlr = 0.001 Performance Metrics and Uncertainty Visualization Performance was evaluated using metrics such as Dice Score, AUROC, TPR, FPR, and Standard Deviation The Dice Score, a critical metric, assesses the congruence between the clinical ground truth labels and the model’s segmentation accuracy The overall uncertainty prediction were on the lower end (less than 1%), with select individual ROI’s within an input image showing uncertainties as high as 20% The overall uncertainty prediction were on the lower end (less than 1%), with select individual ROI’s within an input image showing uncertainties as high as 20% The segregated uncertainty maps for TFS models, augmented with MCD or backprop, are shown in Fig.

Rosa: 2 The segregated uncertainty maps for TFS models, augmented with MCD or backprop, are shown in Fig.

Dev: 2 These visualizations can identify histopathology images with tumors by interpreting high segmentation uncertainties and the reliability of the model’s output to inform clinical decision-making These visualizations can identify histopathology images with tumors by interpreting high segmentation uncertainties and the reliability of the model’s output to inform clinical decision-making Region-Specific Performance Modeling A new algorithm (Algorithm 1) was proposed to calculate region-specific uncertainty, and linear models were developed to predict Dice scores using clinical region-specific uncertainties derived from the MCD model A new algorithm (Algorithm 1) was proposed to calculate region-specific uncertainty, and linear models were developed to predict Dice scores using clinical region-specific uncertainties derived from the MCD model The resulting linear models use constants and uncertainty measures from the clinical ROIs, either individually or combined, to accurately predict model performance (Dice) These linear models use constants and uncertainty measures from the clinical ROIs, either individually or combined, to accurately predict model performance (Dice) For instance, Equation 3 calculates the Dice of the segmentation model based on a linear combination of tumor-tissue, nontumor tissue and non-tissue uncertainties Eq.

Rosa: 3 calculated the Dice of the segmentation model based on a linear combination of tumor-tissue, nontumor tissue and non-tissue uncertainties Clinical Interpretation of Uncertainty The analysis revealed that a more negative coefficient implies a greater reduction in Dice scores A more negative coefficient implies a greater reduction in Dice scores For tumor-containing images, nontumor tissue region uncertainties had the highest coefficient value, meaning they had the largest negative impact on performance For tumor-containing images, nontumor tissue region uncertainties had the highest coefficient value, meaning they had the largest negative impact on performance This indicates that the MCD model was most affected by non-tumor tissue uncertainty, followed by tumor-tissue regions The MCD model was most affected by non-tumor tissue uncertainty, followed by tumor-tissue regions This study demonstrates that region-based linear models can predict deep learning performance (Dice) using clinically meaningful uncertainty estimates This study demonstrates that region-based linear models can predict deep learning performance (Dice) using clinically meaningful uncertainty estimates It is the first time three distinct clinical region-based uncertainties—tumor, non-tumor, and non-tissue regions—were decoupled and analyzed To our knowledge, this is the first time, three distinct clinical region-based uncertainties—tumor, non-tumor, and non-tissue regions—were decoupled and analyzed Future research could apply these uncertainty quantification techniques to other medical imaging datasets for greater model reliability Future research could apply these uncertainty quantification techniques to other medical imaging datasets for greater model reliability The study lays the groundwork for applying these uncertainty estimation methods to other datasets and clinical contexts it lays the groundwork for applying these uncertainty estimation methods to other datasets and clinical contexts All resources, results, code, models, and data from this study are available on GitHub https://github.com/Prof-Pratik-Shah-Lab-UCI/Prostate Project 2024 upon request to the corresponding author All resources, results, code, models, and data from this study are available on GitHub https://github.com/Prof-Pratik-Shah-Lab-UCI/Prostate Project 2024 upon request to the corresponding author REFERENCE arXiv:2109.00115v2 [eess.

Title and authors: Rosa: So we're looking at this paper titled "Deep Learning with Uncertainty Quantification for Predicting the Segmentation Dice Coefficient of Prostate Cancer Biopsy Images." It seems they're taking deep learning models that do segmentation and adding uncertainty estimates to see if those estimates actually help us know how good the model is.

Dev: Right, so the core idea here is using these uncertainty measures, especially from Monte Carlo dropout, to create a better way to evaluate segmentation performance than just looking at the Dice score alone. It suggests that correlating image-level uncertainties with those Dice scores can give us more reliable predictions about where a model is actually struggling.

Taro: I'm thinking about how this could help when we're testing systems outside of the lab, Rosa, because if we have a map showing high uncertainty in certain areas, we know exactly which images are risky and need human review.

Rosa: Exactly! And this study shows they trained their model using randomly initialized weights and Monte Carlo dropout to segment tumors from prostate core biopsy histology RGB images. They're not just looking at the overall score, but they're looking at performance on specific regions.

Dev: That’s key because it moves beyond just a single Dice score for the whole image. They are using this uncertainty quantification in the decoder to mitigate noise during the encoding process, which is a technical detail about how they built the model to get these estimates >

Taro: And what's interesting is that they didn't just stop at calculating an overall uncertainty prediction, which is usually low, like less than one percent. They focused on looking at specific regions within an image where the uncertainties could be as high as twenty percent >

Rosa: That’s because those visualizations of segregated uncertainty maps, augmented with Monte Carlo dropout or backpropagation, are what they use to identify histopathology images with tumors by interpreting those high segmentation uncertainties >

Dev: So they propose a new algorithm, Algorithm one, to calculate that region-specific uncertainty and then build linear models to predict the Dice scores using clinical region-specific uncertainties derived from the Monte Carlo dropout model >

Taro: That sounds like they're trying to quantify exactly how much each type of tissue—tumor versus non-tumor—is hurting the overall segmentation performance, which is a really detailed way to look at it >

Rosa: It turns out that their analysis showed that a more negative coefficient in those linear models implies a greater reduction in Dice scores, and they found that nontumor tissue region uncertainties had the highest coefficient value, meaning they had the largest negative impact on performance >

Dev: That’s significant because it tells us where to focus our improvement efforts if we want to boost segmentation accuracy >

Taro: So, for someone just listening who doesn't know deep learning terms, this means we can look at a biopsy image and get a warning flag based on the uncertainty map itself, not just the final blurry mask >

Rosa: It really lays the groundwork for applying these uncertainty estimation methods to other datasets and clinical contexts because it shows that these region-based linear models can actually predict deep learning performance using clinically meaningful uncertainty estimates >

Dev: That’s a big step. The paper also highlights that it’s the first time three distinct clinical region-based uncertainties—tumor, non-tumor, and non-tissue regions—were decoupled and analyzed >

Taro: I mean decoupling them is what makes this useful for real clinical decision making because you get separate insights into how different parts of the tissue segmentation are performing >

Rosa: So to wrap up on this paper, "Deep Learning with Uncertainty Quantification for Predicting the Segmentation Dice Coefficient of Prostate Cancer Biopsy Images," it demonstrates that region-based linear models can predict deep learning performance using clinically meaningful uncertainty estimates >

Dev: It's important to remember that their findings show how these uncertainties can be used to inform clinical decision-making by visualizing high segmentation uncertainties and the reliability of the model’s output >

Taro: For my part, I think this opens a door for applying these quantification techniques to other medical imaging datasets for greater model reliability because we now have a way to measure risk locally on an image >

Rosa: It's exciting stuff because it connects the mathematical uncertainty of the AI directly to a tangible clinical metric like Dice score >

Dev: We’ll keep an eye on how they apply this framework to different types of imaging data next, and that should give us a clearer picture of its broader applicability >

The paper's summary: Rosa: So we’re looking at this paper that takes deep learning models for prostate biopsy images and adds uncertainty estimates to see if those estimates actually tell us how good the segmentation is.

Dev: Right, so they’re using something called Monte Carlo dropout to figure out where the model is uncertain. The idea is to correlate that pixel-level uncertainty with the Dice score, which is just a way we measure how much the AI's mask matches what a human expert has labeled.

Rosa: Exactly. They train this Bayesian VGG-UNet CNN on those H andE stained RGB images from the MICCAI dataset. It’s not just about getting one final number; they want to know *why* it got that number and where it might be guessing wrong.

Dev: The methodology involves putting that uncertainty quantification right in the decoder part of the network, using Monte Carlo dropout to approximate a Bayesian inference by minimizing a posterior distribution. That’s a technical way of saying they are trying to approximate what the model *really* knows about its own errors during encoding.

Rosa: And they don't just stop there. They generate these uncertainty maps, and they find that while the overall prediction uncertainty is usually low, some individual areas can show up with uncertainties as high as twenty percent.

Dev: That’s where it gets practical for real-time systems. These segregated uncertainty maps let you look at a slide and immediately see which parts of the tumor boundary the AI is least confident about, which helps you prioritize your review of those images.

Rosa: They then build these region-specific linear models—Algorithm one—to predict the final Dice score based on how much uncertainty there is in different areas: tumor tissue, non-tumor tissue, and just general non-tissue stuff.

Dev: That’s a very specific prediction. For instance, they found that the uncertainty coming from the non-tumor tissue region had the biggest negative effect on the overall Dice score. This tells you exactly where your model is most likely to fail when looking at a tumor image.

Rosa: So for someone just listening, this means instead of just getting a fuzzy segmentation mask, you get a map showing high risk areas based on how confused the AI is about that specific tissue type.

Dev: It’s moving from an all-or-nothing performance check to a localized risk assessment, which is crucial when you’re designing systems for clinical use.

Rosa: This whole framework sets the stage for applying this uncertainty quantification to other medical imaging datasets, showing how region-based models can predict accuracy using these clinically meaningful estimates.

Dev: It's interesting because they managed to decouple the uncertainties into three distinct categories—tumor, non-tumor, and non-tissue—and then measure how much each one impacts the Dice score.

Rosa: That level of detail is what makes this work for someone trying to build a more reliable diagnostic tool. Next up, we’ll look at how these uncertainty maps might translate into actual clinical decision making.

The paper's improvements: Rosa: So we're looking at how the authors suggest improving their model’s performance using these uncertainty estimates they generated from Monte Carlo dropout.

Dev: Right, so instead of just using those raw uncertainties to predict the Dice score, they propose a new way—Algorithm one—to calculate region-specific uncertainty for tumor tissue, non-tumor tissue, and non-tissue regions separately.

Rosa: That’s the improvement we’re talking about. It moves beyond just a global measure of confusion; it tries to isolate which specific part of the image is causing the biggest drop in accuracy.

Dev: The idea is to build linear models using those specific regional uncertainties, combining them with constants, and then use that combination to predict the Dice score more accurately than before.

Rosa: It means you’re not just looking at one big error number; you’re getting a breakdown of why the segmentation might be failing for a particular biopsy image.

Dev: That sounds like it could help us build better safety cases for real-time systems because we can predict exactly when the uncertainty in a specific tissue type crosses a threshold that signals failure.

Rosa: If you can predict the Dice score based on those known regional uncertainties, it gives you a much more reliable prediction of the AI's actual performance before it even runs.

Dev: I see how that translates to latency issues. If we know the expected uncertainty from different regions, we can set better expectations for our real-time loops and handle those failure modes gracefully.

Rosa: It’s like having a local warning system built right into the AI’s evaluation process, not just a final output score at the end of everything.

Dev: That localized risk assessment is what matters when we think about real-world deployment, because you can decide exactly how much trust to place in the system for that specific image.

Rosa: So this shifts the focus from "is it good overall?" to "how confident am I in this specific area?" and that’s a big change for clinical use.

Dev: It certainly gives us more concrete numbers to work with when we talk about latency and error bounds in the deployment phase.

Rosa: And since this uncertainty quantification is so detailed, it opens up possibilities for applying these methods to other medical imaging datasets where you need that kind of granular performance tracking.

Conclusion: Rosa: So we've looked at how this paper uses uncertainty estimates to predict segmentation performance for prostate biopsy images using Monte Carlo dropout, and it’s clear this is about making AI models more honest about their own errors.

Dev: Exactly. The core finding is that you can use region-specific uncertainties—tumor tissue versus non-tumor tissue—to build linear models that actually predict the final Dice score pretty well.

Rosa: It means for a field roboticist, we have a better way to know when an AI model is likely to give us a bad result on a specific type of biopsy slide before we even look at it closely.

Dev: From a controls engineer point of view, that’s vital because it gives us more concrete metrics for setting safety cases and understanding the failure modes in real-time loops.

Taro: I just think the fact that they managed to decouple those three distinct uncertainties—tumor, non-tumor, and non-tissue—is really important for understanding how different parts of the pathology are behaving differently during segmentation.

Rosa: It is a big step because it shows that we can get this level of localized performance modeling without losing much predictive capability when we combine those uncertainty measures.

Dev: The caveat is that they are using these techniques on histology images, and while the results look promising, we still need to test how robust these linear models are when you move them to totally different types of medical data.

Taro: That’s fair; applying this framework to other imaging datasets will be a big test for its generalizability outside of prostate tissue.

Rosa: It certainly is, but the groundwork they’ve laid here with these region-based models gives us a solid starting point for applying uncertainty quantification to other medical imaging contexts where reliability is everything.

Dev: So we’re looking at using image uncertainty not just as a diagnostic tool, but as a direct measure of the AI's performance itself.

Rosa: Right, so this study on "Deep Learning with Uncertainty Quantification for Predicting the Segmentation Dice Coefficient of Prostate Cancer Biopsy Images" shows that by quantifying model uncertainty at the pixel level and mapping it to regional performance metrics, we can get much more reliable predictions from deep learning models.

Dev: It’s a solid foundation for how we evaluate and deploy these systems in clinical settings.

Taro: That groundwork is what lets us start testing how these reliability measures translate into actual autonomy when the world misbehaves.

Massachusetts Institute of Tech. · University of California Irvine

eess.IV, cs.CV, cs.LG

Submitted: 2021-08-31

Updated: 2024-12-27

Comments: Presented at the 2024 IEEE International Conference on Machine Learning and Applications (ICMLA), accepted for publication and in press by IEEE

Journal ref: 2024 23rd International Conference on Machine Learning and Applications (ICMLA), IEEE, pp. 1158-1163, 2024

DOI: 10.1109/ICMLA61862.2024.00178

Project page: https://gleason2019.grandchallenge.org

License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/

Importance score: 83/100

The gist: Deep learning models trained with uncertainty estimations can provide more reliable predictions by correlating image-level uncertainties with segmentation performance metrics like Dice scores This…

Key concepts

Bayesian VGG-UNet CNN augmented with Monte Carlo Dropout (MCD)
This is a deep learning model structure enhanced with MCD. MCD introduces uncertainty estimation by running the model multiple times on the same input using dropout layers. This process helps approximate Bayesian inference, allowing the system to quantify how uncertain it is about its segmentation prediction for each pixel.
Dice Score
The Dice Score is a crucial metric used to measure how well a model's predicted tumor segmentation matches the actual clinical ground truth labels. A higher Dice score indicates better agreement between the model's output and what a pathologist would label as the tumor area.
Region-Specific Uncertainty Modeling
This involves calculating distinct uncertainty values for different tissue regions within an image, such as tumor tissue, non-tumor tissue, and non-tissue. Linear models are then built using these specific uncertainties to accurately predict the overall Dice score of the segmentation model.

Terminology

Summary

Deep learning models trained with uncertainty estimations can provide more reliable predictions by correlating image-level uncertainties with segmentation performance metrics like Dice scores This study reports DLM’s trained with uncertainty estimations, using randomly initialized weights and Monte Carlo dropout, to segment tumors from microscopic Hematoxylin and Eosin dye stained prostate core biopsy histology RGB images

Model Training Methodology

The research utilized a Bayesian VGG-UNet CNN augmented with Monte Carlo dropout (MCD) for uncertainty quantification A Bayesian VGG-UNet CNN augmented with MCD was trained on prostate core biopsy images from the Grand Challenge for Pathology at MICCAI Gleason 2019 dataset Uncertainty quantification was applied in the decoder to mitigate noise during the encoding process, using MCD to approximate Bayesian inference by minimizing the posterior in a deep Gaussian Process Uncertainty quantification was applied in the decoder to mitigate noise during the encoding process, with MCD used to approximate Bayesian inference by minimizing the posterior in a deep Gaussian Process Model training involved hyperparameter optimization, five-fold cross-validation, and advanced performance metrics to ensure a comprehensive evaluation of the segmentation results Model training involved hyperparameter optimization, five-fold crossvalidation, and advanced performance metrics to ensure a comprehensive evaluation of the segmentation results The model was trained for 50 epochs with a batch size of two, using the Adam optimizer with a learning rate set at αlr = 0.001 The model was trained for 50 epochs with a batch size of two, using the Adam optimizer with a learning rate set at αlr = 0. p. 1001

Performance Metrics and Uncertainty Visualization

Performance was evaluated using metrics such as Dice Score, AUROC, TPR, FPR, and Standard Deviation The Dice Score, a critical metric, assesses the congruence between the clinical ground truth labels and the model’s segmentation accuracy The overall uncertainty prediction were on the lower end (less than 1%), with select individual ROI’s within an input image showing uncertainties as high as 20% The overall uncertainty prediction were on the lower end (less than 1%), with select individual ROI’s within an input image showing uncertainties as high as 20% The segregated uncertainty maps for TFS models, augmented with MCD or backprop, are shown in Fig. 2 The segregated uncertainty maps for TFS models, augmented with MCD or backprop, are shown in Fig. p. 2 2 These visualizations can identify histopathology images with tumors by interpreting high segmentation uncertainties and the reliability of the model’s output to inform clinical decision-making These visualizations can identify histopathology images with tumors by interpreting high segmentation uncertainties and the reliability of the model’s output to inform clinical decision-making

Region-Specific Performance Modeling

A new algorithm (Algorithm 1) was proposed to calculate region-specific uncertainty, and linear models were developed to predict Dice scores using clinical region-specific uncertainties derived from the MCD model A new algorithm (Algorithm 1) was proposed to calculate region-specific uncertainty, and linear models were developed to predict Dice scores using clinical region-specific uncertainties derived from the MCD model The resulting linear models use constants and uncertainty measures from the clinical ROIs, either individually or combined, to accurately predict model performance (Dice) These linear models use constants and uncertainty measures from the clinical ROIs, either individually or combined, to accurately predict model performance (Dice) For instance, Equation 3 calculates the Dice of the segmentation model based on a linear combination of tumor-tissue, nontumor tissue and non-tissue uncertainties Eq. 3 calculated the Dice of the segmentation model based on a linear combination of tumor-tissue, nontumor tissue and non-tissue uncertainties

Clinical Interpretation of Uncertainty

The analysis revealed that a more negative coefficient implies a greater reduction in Dice scores A more negative coefficient implies a greater reduction in Dice scores For tumor-containing images, nontumor tissue region uncertainties had the highest coefficient value, meaning they had the largest negative impact on performance For tumor-containing images, nontumor tissue region uncertainties had the highest coefficient value, meaning they had the largest negative impact on performance This indicates that the MCD model was most affected by non-tumor tissue uncertainty, followed by tumor-tissue regions The MCD model was most affected by non-tumor tissue uncertainty, followed by tumor-tissue regions

Conclusion and Future Directions

This study demonstrates that region-based linear models can predict deep learning performance (Dice) using clinically meaningful uncertainty estimates This study demonstrates that region-based linear models can predict deep learning performance (Dice) using clinically meaningful uncertainty estimates It is the first time three distinct clinical region-based uncertainties—tumor, non-tumor, and non-tissue regions—were decoupled and analyzed To our knowledge, this is the first time, three distinct clinical region-based uncertainties—tumor, non-tumor, and non-tissue regions—were decoupled and analyzed Future research could apply these uncertainty quantification techniques to other medical imaging datasets for greater model reliability Future research could apply these uncertainty quantification techniques to other medical imaging datasets for greater model reliability The study lays the groundwork for applying these uncertainty estimation methods to other datasets and clinical contexts it lays the groundwork for applying these uncertainty estimation methods to other datasets and clinical contexts All resources, results, code, models, and data from this study are available on GitHub https://github.com/Prof-Pratik-Shah-Lab-UCI/Prostate Project 2024 upon request to the corresponding author All resources, results, code, models, and data from this study are available on GitHub https://github. p. 5com/Prof-Pratik-Shah-Lab-UCI/Prostate Project 2024 upon request to the corresponding author

REFERENCE

arXiv:2109.00115v2 [eess. p. 0

Green — the paper says it, and the page is printed. Red — no passage carries it, so treat that sentence as unverified. The same check runs on your own text: check a summary against its source, $5.

Improvements for AI systems

  1. Bayesian VGG-UNet CNN augmented with Monte Carlo Dropout (MCD) can be used to calculate pixel-level uncertainty for accurate segmentation of prostate biopsy tumors from H&E-stained RGB images. This allows the system to produce detailed uncertainty maps that correlate with Dice coefficients, offering a more clinically relevant evaluation of model accuracy.

  2. The system can generate three distinct clinical region-based uncertainties: tumor tissue uncertainty, non-tumor tissue uncertainty, and non-tissue uncertainty. These maps are then fed into linear models (Algorithm 1) to predict Dice scores using combinations of these regional uncertainties, providing a comprehensive performance metric without loss in predictive capability with low Root Mean Square Error.

  3. The improved system can perform unsupervised performance estimation by calculating the Dice score based on a linear combination of tumor-tissue, nontumor tissue, and non-tissue uncertainties. This allows for the prediction of Dice scores guided by overall uncertainty (Equation 5), aiding in clinical decision-making through visualization of high segmentation uncertainties.

Sources

Related papers